Obtaining approval for drugs for endometriosis and Crohn’s disease and filing an additional application
First written in FY2017. 1 of 2 entries say "Advanced", first in FY2018. Latest entry: FY2018.
3 other companies' latest entry also says "Advanced".
- FY2018AdvancedAnnual report
「During the consolidated fiscal year, approval was obtained for one generic product containing one active ingredient for the treatment of endometriosis. Applications were also submitted for approval of 2 generic products containing 2 active ingredients, comprising one contraceptive product containing one active ingredient and one product for infertility treatment containing one active ingredient.」
The company reports an update in the development stages, having obtained approval for one product containing one active ingredient for the treatment of endometriosis and submitted applications for approval of a total of 2 products containing 2 active ingredients for contraception and infertility treatment. - FY2017First statedAnnual report
「For generic drugs, approval was obtained for 2 products containing 2 active ingredients, comprising a treatment for endometriosis and a treatment for Crohn's disease. An application was also submitted for approval of one generic product containing one active ingredient for the treatment of endometriosis.」
The company reports concrete development progress comprising approval of 2 generic products containing 2 active ingredients and an application for approval of one product containing one active ingredient.